These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18347258)

  • 1. Identification of Id1 in acquired middle ear cholesteatoma.
    Zhang QA; Hamajima Y; Zhang Q; Lin J
    Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):306-10. PubMed ID: 18347258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of inhibitor of DNA-binding (Id1) in hyperproliferation of keratinocytes: the pathological basis for middle ear cholesteatoma from chronic otitis media.
    Hamajima Y; Komori M; Preciado DA; Choo DI; Moribe K; Murakami S; Ondrey FG; Lin J
    Cell Prolif; 2010 Oct; 43(5):457-63. PubMed ID: 20887552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
    Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma.
    Liu W; Ren H; Ren J; Yin T; Hu B; Xie S; Dai Y; Wu W; Xiao Z; Yang X; Xie D
    Mediators Inflamm; 2013; 2013():651207. PubMed ID: 24311896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the angiogenesis of acquired middle ear cholesteatomas by inhibitor of DNA binding transcription factor.
    Fukudome S; Wang C; Hamajima Y; Ye S; Zheng Y; Narita N; Sunaga H; Fujieda S; Hu X; Feng L; Lin J
    JAMA Otolaryngol Head Neck Surg; 2013 Mar; 139(3):273-8. PubMed ID: 23657791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fascin expression in cholesteatoma: correlation with destruction of the ossicular chain and extent of disease.
    Binnetoglu A; Sari M; Baglam T; Erbarut Seven I; Yumusakhuylu AC; Topuz MF; Batman C
    Clin Otolaryngol; 2015 Aug; 40(4):335-40. PubMed ID: 25581788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein.
    Huang CC; Chen CT; Huang TS; Shinoda H
    Eur Arch Otorhinolaryngol; 1996; 253(7):385-9. PubMed ID: 8891480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
    Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
    Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of interleukin-1 in middle ear cholesteatoma.
    Shiwa M; Kojima H; Kamide Y; Moriyama H
    Am J Otolaryngol; 1995; 16(5):319-24. PubMed ID: 7503375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
    Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
    Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is reuse of autologous ear ossicles in cholesteatoma or chronic suppurative otitis media justified?].
    Peng JC; Hoppe F
    Laryngorhinootologie; 1994 Jul; 73(7):375-80. PubMed ID: 7916783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock proteins in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Otolaryngol Head Neck Surg; 1996 Jan; 114(1):77-83. PubMed ID: 8570255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.
    Welkoborsky HJ; Jacob RS; Hinni ML
    Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):841-8. PubMed ID: 17541620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of histopathological aspects and bone destruction characteristics in acquired middle ear cholesteatoma of pediatric and adult patients.
    Aslıer M; Erdag TK; Sarioglu S; Güneri EA; Ikiz AO; Uzun E; Özer E
    Int J Pediatr Otorhinolaryngol; 2016 Mar; 82():73-7. PubMed ID: 26857319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin L activity and its inhibitor in human otitis media.
    Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
    J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.
    Szczepanski MJ; Luczak M; Olszewska E; Molinska-Glura M; Zagor M; Krzeski A; Skarzynski H; Misiak J; Dzaman K; Bilusiak M; Kopec T; Leszczynska M; Witmanowski H; Whiteside TL
    J Mol Med (Berl); 2015 Mar; 93(3):305-14. PubMed ID: 25385222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium.
    Liu W; Xie S; Chen X; Rao X; Ren H; Hu B; Yin T; Xiang Y; Ren J
    Int J Clin Exp Pathol; 2014; 7(2):709-15. PubMed ID: 24551293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of NLRP3 inflammasome in human middle ear cholesteatoma and chronic otitis media.
    Kariya S; Okano M; Zhao P; Kataoka Y; Yoshinobu J; Maeda Y; Ishihara H; Higaki T; Nishizaki K
    Acta Otolaryngol; 2016; 136(2):136-40. PubMed ID: 26457439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.